Humanin
Mitochondrial-derived peptide encoded inside mitochondrial DNA. Studied for neuroprotection, insulin sensitivity, cellular survival.
Humanin is a peptide your mitochondria make and secrete. It's tied to neuroprotection, insulin sensitivity, and cellular survival. Slow, subtle effects — mostly used as a longevity-stack add-on.
Mitochondrial-derived peptide. Naturally produced; exogenous use is a different question.
Not FDA approved.
Not formally categorized in the FDA bulks lists.
Not prescribed in conventional medicine.
Who it's for
- →Users running longevity-focused stacks
- →Older adults targeting metabolic and neuroprotective markers
- →Cellular bioenergetics enthusiasts
What to expect
- Week 1
Subtle. Energy and mood lift first for responders.
- Week 4
Cumulative metabolic / cognitive support.
- Week 8
Plateau. Cycle off.
How it works (mechanism)
Mitochondrial-derived peptide encoded inside mitochondrial DNA. Binds receptors that activate STAT3 and reduce apoptosis, particularly in neurons and pancreatic beta cells.
Dosing protocol
1-10 mg sub-q daily. Casual users start at 1-3 mg.
Stacks well with
Side effects
When NOT to use
- ⚠Pregnancy / nursing
- ⚠No data in active malignancy
Bloodwork to monitor
- • Fasting glucose / insulin if running longer
Common mistakes
- • Expecting fast or visible effects (it's slow and subtle)
- • Stacking with too many longevity peptides simultaneously
- • Running indefinitely — limited human safety data
Educational only. User-specific dosing is between you and a qualified provider.
Frequently asked
What is Humanin?+
Is Humanin FDA approved?+
Is Humanin banned by WADA?+
Are you still natty after taking Humanin?+
Do doctors prescribe Humanin?+
What's the typical dose of Humanin?+
What are the side effects of Humanin?+
How long until Humanin starts working?+
More in Longevity
Tetrapeptide derived from epithalamin. Studied for telomerase activation and circadian / pineal support. Limited human data.
Russian-origin tetrapeptide aimed at brain aging and circadian function. Limited human data — treat as experimental.
FOXO4 dominant-negative interfering peptide. Selectively triggers apoptosis in senescent cells by disrupting FOXO4-p53 interaction. Animal-model senolytic with strong age-reversal data in mice.
A family of short (2-4 amino acid) peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology. Tissue-specific organ-support peptides. Limited Western clinical data.